PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Career Masterclass (CM) is an e-learning platform that seeks to level the playing field for professionals from under-represented or under-served groups by giving them practical guidance from successful industry leaders. It aims to become a contender in the Learning and Development (L&D) market that is valued at £40 billion in the UK. The company asserts that there is a 57% consensus amongst leaders that soft skills such as communication, negotiation, personal branding, and leadership are more important than technical skills. CM aspires to fulfil this objective. It has onboarded clients such as Google, Natwest, HSBC, Barclays Bank, and McDonald's. CM's female CEO and founder has been listed on 'The Powerlist of Britain’s Most Influential People of African and African Caribbean Heritage' for 3 years running. CM will use 45% of the investment for growing its team, 30% for platform and content production, and 25% for marketing and administrative expenses.
days to go:
Expired
investment:
£412,939
Simply rounding up the value of online purchases to the nearest pound and enabling users to save money into a digital wallet. Wishwallet aims to solve the problem of online shopping trolley abandonment, whereby consumers tend to leave products in their online baskets, but not continue to the checkout stage. The company aims to reduce this issue, whilst at the same time allowing customers to afford products and services they not have been able to before.
Wishwallet's revenue stream is comprised of service fees to retailers, advertisements, recurring subscriptions and data. The company aims to launch their service with access to more than 1,500 retailers. They have already completed Phase 1 of their app development cycle and following this investment round, they aim to complete their product to be ready to launch in early 2019. Any additional contributions will be used for marketing campaigns, key hires and future app upgrades.
days to go:
Expired
investment:
£122,140
A UK based house builder specialising in the delivery of high quality, zero carbon Smart Homes in London and South of England. Verto Homes work with a select handful of experienced property investors, purchasing land sites, redeveloping and ultimately selling new build residential properties through single project, special purpose vehicles. It has developments at various stages of construction with a combined Gross Development Value of over £21m in London and the South West of England. Verto Homes is already making sustainable living a reality with the launch of their zero carbon Smart Homes and the company is now on track to become the UK’s largest sustainable house builder by 2020.
http://vertohomes.com/
days to go:
Expired
investment:
£900,000
DiPocket has created a mobile banking app to make instant international bank transfers, with low foreign exchange rates quick and easy. The app is a simple solution to collect and spend money with friends, and it comes with a range of mastercards so it can be used anywhere.
days to go:
Expired
investment:
£157,275
LXCCoin, a 2nd generation crypto currency company with the worlds first 100% asset based cryptocoin with an increasing base value, bridging real-world finance to crypto currencies with its own cryptocoin/P2P loan exchange
days to go:
Expired
investment:
£47,079
Lifetise is a financial planning platform that enables prospective clients to plan significant expenditures such as buying a home, marital expenses, child-rearing and retirement. Presently, they have come up with two major offerings: Homefinder and Childminder. The first one acts as a tool that shows money required to afford a home in the UK and the amount of time taken to save the money while the latter helps parents to calculate the costs of childcare along with their work. Lifetise is targeting the 25-40 age group in the UK whose population numbers are approximately 14 million. To date, they have been featured in prominent publications like Evening Standard and Stylist with an active following on Reddit. The company has secured 12,000 customers after their partnering with Accenture's Fintech Accelerator Programme. With the investment, Lifetise will spend more on developing its applications with a focus on all major life expenditures, marketing on social media channels, build partnerships and human resources.
days to go:
Expired
investment:
£254,240
